Lv32
230 积分 2023-09-26 加入
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
6小时前
待确认
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
21小时前
已完结
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
12天前
已完结
Real-world multicenter study of T-DXd treatment in Chinese patients with metastatic breast cancer
20天前
已完结
Regorafenib as maintenance therapy after first-line doxorubicin-based chemotherapy in advanced non-adipocytic soft tissue sarcomas patients: a double-blind randomised trial
25天前
已关闭
Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
1个月前
已完结
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2个月前
已完结
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2个月前
已完结
Optimizing the safety of antibody-drug conjugates for patients with solid tumours
2个月前
已完结
Treatment advances across the cervical cancer spectrum
2个月前
已完结
皖公网安备34019202002308
